| Gene symbol | TP53 | Synonyms | BCC7, BMFS5, LFS1, P53, TRP53 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17p13.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | tumor protein p53 | ||||
| GTO ID | GTC1900 |
| Trial ID | NCT03544723 |
| Disease | Head and Neck Squamous Cell Carcinoma |
| Altered gene | P53 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | AdV-p53 |
| Phase | Phase2 |
| Recruitment status | Unknown |
| Title | A Phase 2, Multi-Center, Open Label Study to Evaluate Adenoviral p53 (Ad-p53) in Combination With Immune Checkpoint Inhibitor Therapy in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Tumors Approved for Anti-PD-1 or Anti-PD-L1 Therapy |
| Year | 2018 |
| Country | United States |
| Company sponsor | MultiVir, Inc. |
| Other ID(s) | Ad-p53-002 |
| Vector information | |||||||||
|
|||||||||
| Cohort 1 | |||||||
|
|||||||